1. Home
  2. Recombinant Proteins and Antibody Research Tools
  3. SARS-CoV-2 Recombinant Proteins
  4. SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen South African Variant with B.1.351 RBD Mutations (1 mg)

SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen South African Variant with B.1.351 RBD Mutations (1 mg)

£1,700.00

1 mg

SKU: BSV-COV-PR-63

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. Spike protein of the mutant strain B.1.351, also commonly known as the “South Africa Variant”. It is a full-length protein, which is active in its native trimeric form, that is stabilized in LMNG detergent.

SARS-COV-2 Spike Antigen Variants Factsheet

SARS-CoV-2 Spike Antigen Variants MSDS

SA Variant w B.1.351 RBD Mutations_Datasheet

 

Features

Product Name: SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen (South African Variant)
WHO Reference: 501Y.V2/501.V2
UniProt Number: P0DTC2
SARS-CoV-2 Protein: South African Mutation B.1.351
Host: HEK293
Mutations that differ from SPIKE Protein: del 144, K417N, E484K, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H
Further Modifications: Furin cleavage site “RRAR” mutated to “GSAG”; KV986PP
Buffer Composition: 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG
Molecular Weight (Trimeric): 3 x 142 kDa = 426 kDa

Menu